Your gluten sensitivity might be something else entirely, new study shows
Social media and lifestyle magazines have turned gluten—a protein in wheat, rye and barley—into a dietary villain.
Oct 23, 2025
0
78
MeSH tree: C06.405.469.637.250
Social media and lifestyle magazines have turned gluten—a protein in wheat, rye and barley—into a dietary villain.
Oct 23, 2025
0
78
A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Cincinnati ...
Sep 29, 2025
0
69
A new comprehensive atlas of cells fills gaps in knowledge on how different cells in the intestine act together to drive celiac disease, potentially opening new avenues for future therapeutic intervention.
Aug 18, 2025
0
27
In a comprehensive study, researchers from the Department of Epidemiology at the Faculty of Medicine at the University of Augsburg have provided reliable evidence for a link between chronic inflammatory diseases and the development ...
Aug 12, 2025
0
24
In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.
Jul 30, 2025
0
153
Imagine having to eat something that makes you sick—just to see what's making you ill in the first place.
Jun 9, 2025
0
23
Around 1 in 10 Australians say they follow a gluten-free diet.
Jun 4, 2025
0
11
Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium.
Jun 3, 2025
0
13
If we have an allergy to peanuts, strawberries or dairy, we are quick to blame our immune systems. But when we enjoy a diverse diet without any adverse reaction, we generally don't realize that this is also the immune system's ...
May 29, 2025
0
33
An investigational treatment for celiac disease effectively controls the condition—at least in an animal model—in a first-of-its-kind therapeutic for a condition that affects approximately 70 million people worldwide.